Global Dermal Filler and Botolinum Toxin Market Growth 2020-2025
According to this study, over the next five years the Dermal Filler and Botolinum Toxin market will register a xx%% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Dermal Filler and Botolinum Toxin business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Dermal Filler and Botolinum Toxin market by product type, application, key manufacturers and key regions and countries.
This study specially analyses the impact of Covid-19 outbreak on the Dermal Filler and Botolinum Toxin, covering the supply chain analysis, impact assessment to the Dermal Filler and Botolinum Toxin market size growth rate in several scenarios, and the measures to be undertaken by Dermal Filler and Botolinum Toxin companies in response to the COVID-19 epidemic.
Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.
Hyaluronic Acid Based Fillers
Non-Hyaluronic Acid Based Fillers
Botulinum Toxin
Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.
Aesthetic Restoration
Wrinkle Reduction
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Allergan
Medy-Tox
Galderma
Anika Therapeutics
Suneva Medical
Merz Pharma GmbH & Co. KGaA
Grex Pharma
Contura
Daewoong Pharmaceuticals
HUGEL
TEOXANE Laboratories
SciVision Biotech
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Dermal Filler and Botolinum Toxin consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Dermal Filler and Botolinum Toxin market by identifying its various subsegments.
Focuses on the key global Dermal Filler and Botolinum Toxin manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Dermal Filler and Botolinum Toxin with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Dermal Filler and Botolinum Toxin submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Dermal Filler and Botolinum Toxin Consumption 2015-2025
2.1.2 Dermal Filler and Botolinum Toxin Consumption CAGR by Region
2.2 Dermal Filler and Botolinum Toxin Segment by Type
2.2.1 Hyaluronic Acid Based Fillers
2.2.2 Non-Hyaluronic Acid Based Fillers
2.2.3 Botulinum Toxin
2.3 Dermal Filler and Botolinum Toxin Consumption by Type
2.3.1 Global Dermal Filler and Botolinum Toxin Consumption Market Share by Type (2015-2020)
2.3.2 Global Dermal Filler and Botolinum Toxin Revenue and Market Share by Type (2015-2020)
2.3.3 Global Dermal Filler and Botolinum Toxin Sale Price by Type (2015-2020)
2.4 Dermal Filler and Botolinum Toxin Segment by Application
2.4.1 Aesthetic Restoration
2.4.2 Wrinkle Reduction
2.5 Dermal Filler and Botolinum Toxin Consumption by Application
2.5.1 Global Dermal Filler and Botolinum Toxin Consumption Market Share by Type (2015-2020)
2.5.2 Global Dermal Filler and Botolinum Toxin Value and Market Share by Type (2015-2020)
2.5.3 Global Dermal Filler and Botolinum Toxin Sale Price by Type (2015-2020)
3 Global Dermal Filler and Botolinum Toxin by Company
3.1 Global Dermal Filler and Botolinum Toxin Sales Market Share by Company
3.1.1 Global Dermal Filler and Botolinum Toxin Sales by Company (2018-2020)
3.1.2 Global Dermal Filler and Botolinum Toxin Sales Market Share by Company (2018-2020)
3.2 Global Dermal Filler and Botolinum Toxin Revenue Market Share by Company
3.2.1 Global Dermal Filler and Botolinum Toxin Revenue by Company (2018-2020)
3.2.2 Global Dermal Filler and Botolinum Toxin Revenue Market Share by Company (2018-2020)
3.3 Global Dermal Filler and Botolinum Toxin Sale Price by Company
3.4 Global Dermal Filler and Botolinum Toxin Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global Dermal Filler and Botolinum Toxin Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Dermal Filler and Botolinum Toxin Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Dermal Filler and Botolinum Toxin by Regions
4.1 Dermal Filler and Botolinum Toxin by Regions
4.2 Americas Dermal Filler and Botolinum Toxin Consumption Growth
4.3 APAC Dermal Filler and Botolinum Toxin Consumption Growth
4.4 Europe Dermal Filler and Botolinum Toxin Consumption Growth
4.5 Middle East & Africa Dermal Filler and Botolinum Toxin Consumption Growth
5 Americas
5.1 Americas Dermal Filler and Botolinum Toxin Consumption by Countries
5.1.1 Americas Dermal Filler and Botolinum Toxin Consumption by Countries (2015-2020)
5.1.2 Americas Dermal Filler and Botolinum Toxin Value by Countries (2015-2020)
5.2 Americas Dermal Filler and Botolinum Toxin Consumption by Type
5.3 Americas Dermal Filler and Botolinum Toxin Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Dermal Filler and Botolinum Toxin Consumption by Regions
6.1.1 APAC Dermal Filler and Botolinum Toxin Consumption by Regions (2015-2020)
6.1.2 APAC Dermal Filler and Botolinum Toxin Value by Regions (2015-2020)
6.2 APAC Dermal Filler and Botolinum Toxin Consumption by Type
6.3 APAC Dermal Filler and Botolinum Toxin Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions
7 Europe
7.1 Europe Dermal Filler and Botolinum Toxin by Countries
7.1.1 Europe Dermal Filler and Botolinum Toxin Consumption by Countries (2015-2020)
7.1.2 Europe Dermal Filler and Botolinum Toxin Value by Countries (2015-2020)
7.2 Europe Dermal Filler and Botolinum Toxin Consumption by Type
7.3 Europe Dermal Filler and Botolinum Toxin Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Dermal Filler and Botolinum Toxin by Countries
8.1.1 Middle East & Africa Dermal Filler and Botolinum Toxin Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Dermal Filler and Botolinum Toxin Value by Countries (2015-2020)
8.2 Middle East & Africa Dermal Filler and Botolinum Toxin Consumption by Type
8.3 Middle East & Africa Dermal Filler and Botolinum Toxin Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Dermal Filler and Botolinum Toxin Distributors
10.3 Dermal Filler and Botolinum Toxin Customer
11 Global Dermal Filler and Botolinum Toxin Market Forecast
11.1 Global Dermal Filler and Botolinum Toxin Consumption Forecast (2021-2025)
11.2 Global Dermal Filler and Botolinum Toxin Forecast by Regions
11.2.1 Global Dermal Filler and Botolinum Toxin Forecast by Regions (2021-2025)
11.2.2 Global Dermal Filler and Botolinum Toxin Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast byRegions
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Dermal Filler and Botolinum Toxin Forecast by Type
11.8 Global Dermal Filler and Botolinum Toxin Forecast by Application
12 Key Players Analysis
12.1 Allergan
12.1.1 Company Information
12.1.2 Dermal Filler and Botolinum Toxin Product Offered
12.1.3 Allergan Dermal Filler and Botolinum Toxin Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 Allergan Latest Developments
12.2 Medy-Tox
12.2.1 Company Information
12.2.2 Dermal Filler and Botolinum Toxin Product Offered
12.2.3 Medy-Tox Dermal Filler and Botolinum Toxin Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 Medy-Tox Latest Developments
12.3 Galderma
12.3.1 Company Information
12.3.2 Dermal Filler and Botolinum Toxin Product Offered
12.3.3 Galderma Dermal Filler and Botolinum Toxin Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 Galderma Latest Developments
12.4 Anika Therapeutics
12.4.1 Company Information
12.4.2 Dermal Filler and Botolinum Toxin Product Offered
12.4.3 Anika Therapeutics Dermal Filler and Botolinum Toxin Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 Anika Therapeutics Latest Developments
12.5 Suneva Medical
12.5.1 Company Information
12.5.2 Dermal Filler and Botolinum Toxin Product Offered
12.5.3 Suneva Medical Dermal Filler and Botolinum Toxin Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 Suneva Medical Latest Developments
12.6 Merz Pharma GmbH & Co. KGaA
12.6.1 Company Information
12.6.2 Dermal Filler and Botolinum Toxin Product Offered
12.6.3 Merz Pharma GmbH & Co. KGaA Dermal Filler and Botolinum Toxin Sales, Revenue, Price and Gross Margin (2018-2020)
12.6.4 Main Business Overview
12.6.5 Merz Pharma GmbH & Co. KGaA Latest Developments
12.7 Grex Pharma
12.7.1 Company Information
12.7.2 Dermal Filler and Botolinum Toxin Product Offered
12.7.3 Grex Pharma Dermal Filler and Botolinum Toxin Sales, Revenue, Price and Gross Margin (2018-2020)
12.7.4 Main Business Overview
12.7.5 Grex Pharma Latest Developments
12.8 Contura
12.8.1 Company Information
12.8.2 Dermal Filler and Botolinum Toxin Product Offered
12.8.3 Contura Dermal Filler and Botolinum Toxin Sales, Revenue, Price and Gross Margin (2018-2020)
12.8.4 Main Business Overview
12.8.5 Contura Latest Developments
12.9 Daewoong Pharmaceuticals
12.9.1 Company Information
12.9.2 Dermal Filler and Botolinum Toxin Product Offered
12.9.3 Daewoong Pharmaceuticals Dermal Filler and Botolinum Toxin Sales, Revenue, Price and Gross Margin (2018-2020)
12.9.4 Main Business Overview
12.9.5 Daewoong Pharmaceuticals Latest Developments
12.10 HUGEL
12.10.1 Company Information
12.10.2 Dermal Filler and Botolinum Toxin Product Offered
12.10.3 HUGEL Dermal Filler and Botolinum Toxin Sales, Revenue, Price and Gross Margin (2018-2020)
12.10.4 Main Business Overview
12.10.5 HUGEL Latest Developments
12.11 TEOXANE Laboratories
12.11.1 Company Information
12.11.2 Dermal Filler and Botolinum Toxin Product Offered
12.11.3 TEOXANE Laboratories Dermal Filler and Botolinum Toxin Sales, Revenue, Price and Gross Margin (2018-2020)
12.11.4 Main Business Overview
12.11.5 TEOXANE Laboratories Latest Developments
12.12 SciVision Biotech
12.12.1 Company Information
12.12.2 Dermal Filler and Botolinum Toxin Product Offered
12.12.3 SciVision Biotech Dermal Filler and Botolinum Toxin Sales, Revenue, Price and Gross Margin (2018-2020)
12.12.4 Main Business Overview
12.12.5 SciVision Biotech Latest Developments
13 Research Findings and Conclusion
Tables and Figures
List of Tables
Table 1. Research Methodology
Table 2. Data Source
Table 3. Dermal Filler and Botolinum Toxin Consumption CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players of Hyaluronic Acid Based Fillers
Table 5. Major Players of Non-Hyaluronic Acid Based Fillers
Table 6. Major Players of Botulinum Toxin
Table 7. Global Consumption Sales by Type (2015-2020)
Table 8. Global Dermal Filler and Botolinum Toxin Consumption Market Share by Type (2015-2020)
Table 9. Global Dermal Filler and Botolinum Toxin Revenue by Type (2015-2020) ($ million)
Table 10. Global Dermal Filler and Botolinum Toxin Value Market Share by Type (2015-2020) ($ Millions)
Table 11. Global Dermal Filler and Botolinum Toxin Sale Price by Type (2015-2020)
Table 12. Global Consumption Sales by Application (2015-2020)
Table 13. Global Dermal Filler and Botolinum Toxin Consumption Market Share by Application (2015-2020)
Table 14. Global Dermal Filler and Botolinum Toxin Value by Application (2015-2020)
Table 15. Global Dermal Filler and Botolinum Toxin Value Market Share by Application (2015-2020)
Table 16. Global Dermal Filler and Botolinum Toxin Sale Price by Application (2015-2020)
Table 17. Global Dermal Filler and Botolinum Toxin Sales by Company (2017-2019) (K MT)
Table 18. Global Dermal Filler and Botolinum Toxin Sales Market Share by Company (2017-2019)
Table 19. Global Dermal Filler and Botolinum Toxin Revenue by Company (2017-2019) ($ Millions)
Table 20. Global Dermal Filler and Botolinum Toxin Revenue Market Share by Company (2017-2019)
Table 21. Global Dermal Filler and Botolinum Toxin Sale Price by Company (2017-2019)
Table 22. Global Dermal Filler and Botolinum Toxin Manufacturing Base Distribution and Sales Area by Manufacturers
Table 23. Players Dermal Filler and Botolinum Toxin Products Offered
Table 24. Dermal Filler and Botolinum Toxin Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
Table 25. Global Dermal Filler and Botolinum Toxin Consumption by Regions 2015-2020 (K MT)
Table 26. Global Dermal Filler and Botolinum Toxin Consumption Market Share by Regions 2015-2020
Table 27. Global Dermal Filler and Botolinum Toxin Value by Regions 2015-2020 ($ Millions)
Table 28. Global Dermal Filler and Botolinum Toxin Value Market Share by Regions 2015-2020
Table 29. Americas Dermal Filler and Botolinum Toxin Consumption by Countries (2015-2020) (K MT)
Table 30. Americas Dermal Filler and Botolinum Toxin Consumption Market Share by Countries (2015-2020)
Table 31. Americas Dermal Filler and Botolinum Toxin Value by Countries (2015-2020) ($ Millions)
Table 32. Americas Dermal Filler and Botolinum Toxin Value Market Share by Countries (2015-2020)
Table 33. Americas Dermal Filler and Botolinum Toxin Consumption by Type (2015-2020) (K MT)
Table 34. Americas Dermal Filler and Botolinum Toxin Consumption Market Share by Type (2015-2020)
Table 35. Americas Dermal Filler and Botolinum Toxin Consumption by Application (2015-2020) (K MT)
Table 36. Americas Dermal Filler and Botolinum Toxin Consumption Market Share by Application (2015-2020)
Table 37. APAC Dermal Filler and Botolinum Toxin Consumption by Regions (2015-2020) (K MT)
Table 38. APAC Dermal Filler and Botolinum Toxin Consumption Market Share by Regions (2015-2020)
Table 39. APAC Dermal Filler and Botolinum Toxin Value by Regions (2015-2020) ($ Millions)
Table 40. APAC Dermal Filler and Botolinum Toxin Value Market Share by Regions (2015-2020)
Table 41. APAC Dermal Filler and Botolinum Toxin Consumption by Type (2015-2020) (K MT)
Table 42. APAC Dermal Filler and Botolinum Toxin Consumption Market Share by Type (2015-2020)
Table 43. APAC Dermal Filler and Botolinum Toxin Consumption by Application (2015-2020) (K MT)
Table 44. APAC Dermal Filler and Botolinum Toxin Consumption Market Share by Application (2015-2020)
Table 45. Europe Dermal Filler and Botolinum Toxin Consumption by Countries (2015-2020) (K MT)
Table 46. Europe Dermal Filler and Botolinum Toxin Consumption Market Share by Countries (2015-2020)
Table 47. Europe Dermal Filler and Botolinum Toxin Value by Countries (2015-2020) ($ Millions)
Table 48. Europe Dermal Filler and Botolinum Toxin Value Market Share by Countries (2015-2020)
Table 49. Europe Dermal Filler and Botolinum Toxin Consumption by Type (2015-2020) (K MT)
Table 50. Europe Dermal Filler and Botolinum Toxin Consumption Market Share by Type (2015-2020)
Table 51. Europe Dermal Filler and Botolinum Toxin Consumption by Application (2015-2020) (K MT)
Table 52. Europe Dermal Filler and Botolinum Toxin Consumption Market Share by Application (2015-2020)
Table 53. Middle East & Africa Dermal Filler and Botolinum Toxin Consumption by Countries (2015-2020) (K MT)
Table 54. Middle East & Africa Dermal Filler and Botolinum Toxin Consumption Market Share by Countries (2015-2020)
Table 55. Middle East & Africa Dermal Filler and Botolinum Toxin Value by Countries (2015-2020) ($ Millions)
Table 56. Middle East & Africa Dermal Filler and Botolinum Toxin Value Market Share by Countries (2015-2020)
Table 57. Middle East & Africa Dermal Filler and Botolinum Toxin Consumption by Type (2015-2020) (K MT)
Table 58. Middle East & Africa Dermal Filler and Botolinum Toxin Consumption Market Share by Type (2015-2020)
Table 59. Middle East & Africa Dermal Filler and Botolinum Toxin Consumption by Application (2015-2020) (K MT)
Table 60. Middle East & Africa Dermal Filler and Botolinum Toxin Consumption Market Share by Application (2015-2020)
Table 61. Dermal Filler and Botolinum Toxin Distributors List
Table 62. Dermal Filler and Botolinum Toxin Customer List
Table 63. Global Dermal Filler and Botolinum Toxin Consumption Forecast by Countries (2021-2025) (K MT)
Table 64. Global Dermal Filler and Botolinum Toxin Consumption Market Forecast by Regions
Table 65. Global Dermal Filler and Botolinum Toxin Value Forecast by Countries (2021-2025) ($ Millions)
Table 66. Global Dermal Filler and Botolinum Toxin Value Market Share Forecast by Regions
Table 67. Global Dermal Filler and Botolinum Toxin Consumption Forecast by Type (2021-2025) (K MT)
Table 68. Global Dermal Filler and Botolinum Toxin Consumption Market Share Forecast by Type (2021-2025)
Table 69. Global Dermal Filler and Botolinum Toxin Value Forecast by Type (2021-2025) ($ Millions)
Table 70. Global Dermal Filler and Botolinum Toxin Value Market Share Forecast by Type (2021-2025)
Table 71. Global Dermal Filler and Botolinum Toxin Consumption Forecast by Application (2021-2025) (K MT)
Table 72. Global Dermal Filler and Botolinum Toxin Consumption Market Share Forecast by Application (2021-2025)
Table 73. Global Dermal Filler and Botolinum Toxin Value Forecast by Application (2021-2025) ($ Millions)
Table 74. Global Dermal Filler and Botolinum Toxin Value Market Share Forecast by Application (2021-2025)
Table 75. Allergan Product Offered
Table 76. Allergan Dermal Filler and Botolinum Toxin Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 77. Allergan Main Business
Table 78. Allergan Latest Developments
Table 79. Allergan Basic Information, Company Total Revenue (in $ million), Dermal Filler and Botolinum Toxin Manufacturing Base, Sales Area and Its Competitors
Table 80. Medy-Tox Product Offered
Table 81. Medy-Tox Dermal Filler and Botolinum Toxin Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 82. Medy-Tox Main Business
Table 83. Medy-Tox Latest Developments
Table 84. Medy-Tox Basic Information, Company Total Revenue (in $ million), Dermal Filler and Botolinum Toxin Manufacturing Base, Sales Area and Its Competitors
Table 85. Galderma Product Offered
Table 86. Galderma Dermal Filler and Botolinum Toxin Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 87. Galderma Main Business
Table 88. Galderma Latest Developments
Table 89. Galderma Basic Information, Company Total Revenue (in $ million), Dermal Filler and Botolinum Toxin Manufacturing Base, Sales Area and Its Competitors
Table 90. Anika Therapeutics Product Offered
Table 91. Anika Therapeutics Dermal Filler and Botolinum Toxin Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 92. Anika Therapeutics Main Business
Table 93. Anika Therapeutics Latest Developments
Table 94. Anika Therapeutics Basic Information, Company Total Revenue (in $ million), Dermal Filler and Botolinum Toxin Manufacturing Base, Sales Area and Its Competitors
Table 95. Suneva Medical Product Offered
Table 96. Suneva Medical Dermal Filler and Botolinum Toxin Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 97. Suneva Medical Main Business
Table 98. Suneva Medical Latest Developments
Table 99. Suneva Medical Basic Information, Company Total Revenue (in $ million), Dermal Filler and Botolinum Toxin Manufacturing Base, Sales Area and Its Competitors
Table 100. Merz Pharma GmbH & Co. KGaA Product Offered
Table 101. Merz Pharma GmbH & Co. KGaA Dermal Filler and Botolinum Toxin Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 102. Merz Pharma GmbH & Co. KGaA Main Business
Table 103. Merz Pharma GmbH & Co. KGaA Latest Developments
Table 104. Merz Pharma GmbH & Co. KGaA Basic Information, Company Total Revenue (in $ million), Dermal Filler and Botolinum Toxin Manufacturing Base, Sales Area and Its Competitors
Table 105. Grex Pharma Product Offered
Table 106. Grex Pharma Basic Information, Company Total Revenue (in $ million), Dermal Filler and Botolinum Toxin Manufacturing Base, Sales Area and Its Competitors
Table 107. Grex Pharma Main Business
Table 108. Grex Pharma Latest Developments
Table 109. Grex Pharma Dermal Filler and Botolinum Toxin Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 110. Contura Product Offered
Table 111. Contura Dermal Filler and Botolinum Toxin Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 112. Contura Main Business
Table 113. Contura Latest Developments
Table 114. Contura Basic Information, Company Total Revenue (in $ million), Dermal Filler and Botolinum Toxin Manufacturing Base, Sales Area and Its Competitors
Table 115. Daewoong Pharmaceuticals Product Offered
Table 116. Daewoong Pharmaceuticals Dermal Filler and Botolinum Toxin Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 117. Daewoong Pharmaceuticals Main Business
Table 118. Daewoong Pharmaceuticals Latest Developments
Table 119. Daewoong Pharmaceuticals Basic Information, Company Total Revenue (in $ million), Dermal Filler and Botolinum Toxin Manufacturing Base, Sales Area and Its Competitors
Table 120. HUGEL Product Offered
Table 121. HUGEL Dermal Filler and Botolinum Toxin Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 122. HUGEL Main Business
Table 123. HUGEL Latest Developments
Table 124. HUGEL Basic Information, Company Total Revenue (in $ million), Dermal Filler and Botolinum Toxin Manufacturing Base, Sales Area and Its Competitors
Table 125. TEOXANE Laboratories Product Offered
Table 126. TEOXANE Laboratories Dermal Filler and Botolinum Toxin Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 127. TEOXANE Laboratories Main Business
Table 128. TEOXANE Laboratories Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 129. TEOXANE Laboratories Latest Developments
Table 130. SciVision Biotech Product Offered
Table 131. SciVision Biotech Dermal Filler and Botolinum Toxin Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 132. SciVision Biotech Main Business
Table 133. SciVision Biotech Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 134. SciVision Biotech Latest Developments
List of Figures
Figure 1. Picture of Dermal Filler and Botolinum Toxin
Figure 2. Dermal Filler and Botolinum Toxin Report Years Considered
Figure 3. Market Research Methodology
Figure 4. Global Dermal Filler and Botolinum Toxin Consumption Growth Rate 2015-2025 (K MT)
Figure 5. Global Dermal Filler and Botolinum Toxin Value Growth Rate 2015-2025 ($ Millions)
Figure 6. Product Picture of Hyaluronic Acid Based Fillers
Figure 7. Product Picture of Non-Hyaluronic Acid Based Fillers
Figure 8. Product Picture of Botulinum Toxin
Figure 9. Global Dermal Filler and Botolinum Toxin Consumption Market Share by Type (2015-2020)
Figure 10. Global Dermal Filler and Botolinum Toxin Value Market Share by Type (2015-2020)
Figure 11. Dermal Filler and Botolinum Toxin Consumed in Aesthetic Restoration
Figure 12. Global Dermal Filler and Botolinum Toxin Market: Aesthetic Restoration (2015-2020) (K MT)
Figure 13. Global Dermal Filler and Botolinum Toxin Market: Aesthetic Restoration (2015-2020) ($ Millions)
Figure 14. Dermal Filler and Botolinum Toxin Consumed in Wrinkle Reduction
Figure 15. Global Dermal Filler and Botolinum Toxin Market: Wrinkle Reduction (2015-2020) (K MT)
Figure 16. Global Dermal Filler and Botolinum Toxin Market: Wrinkle Reduction (2015-2020) ($ Millions)
Figure 17. Global Dermal Filler and Botolinum Toxin Consumption Market Share by Application (2015-2020)
Figure 18. Global Dermal Filler and Botolinum Toxin Value Market Share by Application (2015-2020)
Figure 19. Global Dermal Filler and Botolinum Toxin Sales Market Share by Company in 2017
Figure 20. Global Dermal Filler and Botolinum Toxin Sales Market Share by Company in 2019
Figure 21. Global Dermal Filler and Botolinum Toxin Revenue Market Share by Company in 2017
Figure 22. Global Dermal Filler and Botolinum Toxin Revenue Market Share by Company in 2019
Figure 23. Global Dermal Filler and Botolinum Toxin Sale Price by Company in 2019
Figure 24. Global Dermal Filler and Botolinum Toxin Consumption Market Share by Regions 2015-2020
Figure 25. Global Dermal Filler and Botolinum Toxin Value Market Share by Regions 2015-2020
Figure 26. Americas Dermal Filler and Botolinum Toxin Consumption 2015-2020 (K MT)
Figure 27. Americas Dermal Filler and Botolinum Toxin Value 2015-2020 ($ Millions)
Figure 28. APAC Dermal Filler and Botolinum Toxin Consumption 2015-2020 (K MT)
Figure 29. APAC Dermal Filler and Botolinum Toxin Value 2015-2020 ($ Millions)
Figure 30. Europe Dermal Filler and Botolinum Toxin Consumption 2015-2020 (K MT)
Figure 31. Europe Dermal Filler and Botolinum Toxin Value 2015-2020 ($ Millions)
Figure 32. Middle East & Africa Dermal Filler and Botolinum Toxin Consumption 2015-2020 (K MT)
Figure 33. Middle East & Africa Dermal Filler and Botolinum Toxin Value 2015-2020 ($ Millions)
Figure 34. Americas Dermal Filler and Botolinum Toxin Consumption Market Share by Countries in 2019
Figure 35. Americas Dermal Filler and Botolinum Toxin Value Market Share by Countries in 2019
Figure 36. Americas Dermal Filler and Botolinum Toxin Consumption Market Share by Type in 2019
Figure 37. Americas Dermal Filler and Botolinum Toxin Consumption Market Share by Application in 2019
Figure 38. United States Dermal Filler and Botolinum Toxin Consumption Growth 2015-2020 (K MT)
Figure 39. United States Dermal Filler and Botolinum Toxin Value Growth 2015-2020 ($ Millions)
Figure 40. Canada Dermal Filler and Botolinum Toxin Consumption Growth 2015-2020 (K MT)
Figure 41. Canada Dermal Filler and Botolinum Toxin Value Growth 2015-2020 ($ Millions)
Figure 42. Mexico Dermal Filler and Botolinum Toxin Consumption Growth 2015-2020 (K MT)
Figure 43. Mexico Dermal Filler and Botolinum Toxin Value Growth 2015-2020 ($ Millions)
Figure 44. APAC Dermal Filler and Botolinum Toxin Consumption Market Share by Countries in 2019
Figure 45. APAC Dermal Filler and Botolinum Toxin Value Market Share by Regions in 2019
Figure 46. APAC Dermal Filler and Botolinum Toxin Consumption Market Share by Type in 2019
Figure 47. APAC Dermal Filler and Botolinum Toxin Consumption Market Share by Application in 2019
Figure 48. China Dermal Filler and Botolinum Toxin Consumption Growth 2015-2020 (K MT)
Figure 49. China Dermal Filler and Botolinum Toxin Value Growth 2015-2020 ($ Millions)
Figure 50. Japan Dermal Filler and Botolinum Toxin Consumption Growth 2015-2020 (K MT)
Figure 51. Japan Dermal Filler and Botolinum Toxin Value Growth 2015-2020 ($ Millions)
Figure 52. Korea Dermal Filler and Botolinum Toxin Consumption Growth 2015-2020 (K MT)
Figure 53. Korea Dermal Filler and Botolinum Toxin Value Growth 2015-2020 ($ Millions)
Figure 54. Southeast Asia Dermal Filler and Botolinum Toxin Consumption Growth 2015-2020 (K MT)
Figure 55. Southeast Asia Dermal Filler and Botolinum Toxin Value Growth 2015-2020 ($ Millions)
Figure 56. India Dermal Filler and Botolinum Toxin Consumption Growth 2015-2020 (K MT)
Figure 57. India Dermal Filler and Botolinum Toxin Value Growth 2015-2020 ($ Millions)
Figure 58. Australia Dermal Filler and Botolinum Toxin Consumption Growth 2015-2020 (K MT)
Figure 59. Australia Dermal Filler and Botolinum Toxin Value Growth 2015-2020 ($ Millions)
Figure 60. Europe Dermal Filler and Botolinum Toxin Consumption Market Share by Countries in 2019
Figure 61. Europe Dermal Filler and Botolinum Toxin Value Market Share by Countries in 2019
Figure 62. Europe Dermal Filler and Botolinum Toxin Consumption Market Share by Type in 2019
Figure 63. Europe Dermal Filler and Botolinum Toxin Consumption Market Share by Application in 2019
Figure 64. Germany Dermal Filler and Botolinum Toxin Consumption Growth 2015-2020 (K MT)
Figure 65. Germany Dermal Filler and Botolinum Toxin Value Growth 2015-2020 ($ Millions)
Figure 66. France Dermal Filler and Botolinum Toxin Consumption Growth 2015-2020 (K MT)
Figure 67. France Dermal Filler and Botolinum Toxin Value Growth 2015-2020 ($ Millions)
Figure 68. UK Dermal Filler and Botolinum Toxin Consumption Growth 2015-2020 (K MT)
Figure 69. UK Dermal Filler and Botolinum Toxin Value Growth 2015-2020 ($ Millions)
Figure 70. Italy Dermal Filler and Botolinum Toxin Consumption Growth 2015-2020 (K MT)
Figure 71. Italy Dermal Filler and Botolinum Toxin Value Growth 2015-2020 ($ Millions)
Figure 72. Russia Dermal Filler and Botolinum Toxin Consumption Growth 2015-2020 (K MT)
Figure 73. Russia Dermal Filler and Botolinum Toxin Value Growth 2015-2020 ($ Millions)
Figure 74. Middle East & Africa Dermal Filler and Botolinum Toxin Consumption Market Share by Countries in 2019
Figure 75. Middle East & Africa Dermal Filler and Botolinum Toxin Value Market Share by Countries in 2019
Figure 76. Middle East & Africa Dermal Filler and Botolinum Toxin Consumption Market Share by Type in 2019
Figure 77. Middle East & Africa Dermal Filler and Botolinum Toxin Consumption Market Share by Application in 2019
Figure 78. Egypt Dermal Filler and Botolinum Toxin Consumption Growth 2015-2020 (K MT)
Figure 79. Egypt Dermal Filler and Botolinum Toxin Value Growth 2015-2020 ($ Millions)
Figure 80. South Africa Dermal Filler and Botolinum Toxin Consumption Growth 2015-2020 (K MT)
Figure 81. South Africa Dermal Filler and Botolinum Toxin Value Growth 2015-2020 ($ Millions)
Figure 82. Israel Dermal Filler and Botolinum Toxin Consumption Growth 2015-2020 (K MT)
Figure 83. Israel Dermal Filler and Botolinum Toxin Value Growth 2015-2020 ($ Millions)
Figure 84. Turkey Dermal Filler and Botolinum Toxin Consumption Growth 2015-2020 (K MT)
Figure 85. Turkey Dermal Filler and Botolinum Toxin Value Growth 2015-2020 ($ Millions)
Figure 86. GCC Countries Dermal Filler and Botolinum Toxin Consumption Growth 2015-2020 (K MT)
Figure 87. GCC Countries Dermal Filler and Botolinum Toxin Value Growth 2015-2020 ($ Millions)
Figure 88. Global Dermal Filler and Botolinum Toxin Consumption Growth Rate Forecast (2021-2025) (K MT)
Figure 89. Global Dermal Filler and Botolinum Toxin Value Growth Rate Forecast (2021-2025) ($ Millions)
Figure 90. Americas Dermal Filler and Botolinum Toxin Consumption 2021-2025 (K MT)
Figure 91. Americas Dermal Filler and Botolinum Toxin Value 2021-2025 ($ Millions)
Figure 92. APAC Dermal Filler and Botolinum Toxin Consumption 2021-2025 (K MT)
Figure 93. APAC Dermal Filler and Botolinum Toxin Value 2021-2025 ($ Millions)
Figure 94. Europe Dermal Filler and Botolinum Toxin Consumption 2021-2025 (K MT)
Figure 95. Europe Dermal Filler and Botolinum Toxin Value 2021-2025 ($ Millions)
Figure 96. Middle East & Africa Dermal Filler and Botolinum Toxin Consumption 2021-2025 (K MT)
Figure 97. Middle East & Africa Dermal Filler and Botolinum Toxin Value 2021-2025 ($ Millions)
Figure 98. United States Dermal Filler and Botolinum Toxin Consumption 2021-2025 (K MT)
Figure 99. United States Dermal Filler and Botolinum Toxin Value 2021-2025 ($ Millions)
Figure 100. Canada Dermal Filler and Botolinum Toxin Consumption 2021-2025 (K MT)
Figure 101. Canada Dermal Filler and Botolinum Toxin Value 2021-2025 ($ Millions)
Figure 102. Mexico Dermal Filler and Botolinum Toxin Consumption 2021-2025 (K MT)
Figure 103. Mexico Dermal Filler and Botolinum Toxin Value 2021-2025 ($ Millions)
Figure 104. Brazil Dermal Filler and Botolinum Toxin Consumption 2021-2025 (K MT)
Figure 105. Brazil Dermal Filler and Botolinum Toxin Value 2021-2025 ($ Millions)
Figure 106. China Dermal Filler and Botolinum Toxin Consumption 2021-2025 (K MT)
Figure 107. China Dermal Filler and Botolinum Toxin Value 2021-2025 ($ Millions)
Figure 108. Japan Dermal Filler and Botolinum Toxin Consumption 2021-2025 (K MT)
Figure 109. Japan Dermal Filler and Botolinum Toxin Value 2021-2025 ($ Millions)
Figure 110. Korea Dermal Filler and Botolinum Toxin Consumption 2021-2025 (K MT)
Figure 111. Korea Dermal Filler and Botolinum Toxin Value 2021-2025 ($ Millions)
Figure 112. Southeast Asia Dermal Filler and Botolinum Toxin Consumption 2021-2025 (K MT)
Figure 113. Southeast Asia Dermal Filler and Botolinum Toxin Value 2021-2025 ($ Millions)
Figure 114. India Dermal Filler and Botolinum Toxin Consumption 2021-2025 (K MT)
Figure 115. India Dermal Filler and Botolinum Toxin Value 2021-2025 ($ Millions)
Figure 116. Australia Dermal Filler and Botolinum Toxin Consumption 2021-2025 (K MT)
Figure 117. Australia Dermal Filler and Botolinum Toxin Value 2021-2025 ($ Millions)
Figure 118. Germany Dermal Filler and Botolinum Toxin Consumption 2021-2025 (K MT)
Figure 119. Germany Dermal Filler and Botolinum Toxin Value 2021-2025 ($ Millions)
Figure 120. France Dermal Filler and Botolinum Toxin Consumption 2021-2025 (K MT)
Figure 121. France Dermal Filler and Botolinum Toxin Value 2021-2025 ($ Millions)
Figure 122. UK Dermal Filler and Botolinum Toxin Consumption 2021-2025 (K MT)
Figure 123. UK Dermal Filler and Botolinum Toxin Value 2021-2025 ($ Millions)
Figure 124. Italy Dermal Filler and Botolinum Toxin Consumption 2021-2025 (K MT)
Figure 125. Italy Dermal Filler and Botolinum Toxin Value 2021-2025 ($ Millions)
Figure 126. Russia Dermal Filler and Botolinum Toxin Consumption 2021-2025 (K MT)
Figure 127. Russia Dermal Filler and Botolinum Toxin Value 2021-2025 ($ Millions)
Figure 128. Spain Dermal Filler and Botolinum Toxin Consumption 2021-2025 (K MT)
Figure 129. Spain Dermal Filler and Botolinum Toxin Value 2021-2025 ($ Millions)
Figure 130. Egypt Dermal Filler and Botolinum Toxin Consumption 2021-2025 (K MT)
Figure 131. Egypt Dermal Filler and Botolinum Toxin Value 2021-2025 ($ Millions)
Figure 132. South Africa Dermal Filler and Botolinum Toxin Consumption 2021-2025 (K MT)
Figure 133. South Africa Dermal Filler and Botolinum Toxin Value 2021-2025 ($ Millions)
Figure 134. Israel Dermal Filler and Botolinum Toxin Consumption 2021-2025 (K MT)
Figure 135. Israel Dermal Filler and Botolinum Toxin Value 2021-2025 ($ Millions)
Figure 136. Turkey Dermal Filler and Botolinum Toxin Consumption 2021-2025 (K MT)
Figure 137. Turkey Dermal Filler and Botolinum Toxin Value 2021-2025 ($ Millions)
Figure 138. GCC Countries Dermal Filler and Botolinum Toxin Consumption 2021-2025 (K MT)
Figure 139. GCC Countries Dermal Filler and Botolinum Toxin Value 2021-2025 ($ Millions)
Figure 140. Allergan Dermal Filler and Botolinum Toxin Market Share (2018-2020)
Figure 141. Medy-Tox Dermal Filler and Botolinum Toxin Market Share (2018-2020)
Figure 142. Galderma Dermal Filler and Botolinum Toxin Market Share (2018-2020)
Figure 143. Anika Therapeutics Dermal Filler and Botolinum Toxin Market Share (2018-2020)
Figure 144. Suneva Medical Dermal Filler and Botolinum Toxin Market Share (2018-2020)
Figure 145. Merz Pharma GmbH & Co. KGaA Dermal Filler and Botolinum Toxin Market Share (2018-2020)
Figure 146. Grex Pharma Dermal Filler and Botolinum Toxin Market Share (2018-2020)
Figure 147. Contura Dermal Filler and Botolinum Toxin Market Share (2018-2020)
Figure 148. Daewoong Pharmaceuticals Dermal Filler and Botolinum Toxin Market Share (2018-2020)
Figure 149. HUGEL Dermal Filler and Botolinum Toxin Market Share (2018-2020)
Figure 150. TEOXANE Laboratories Dermal Filler and Botolinum Toxin Market Share (2018-2020)
Figure 151. SciVision Biotech Dermal Filler and Botolinum Toxin Market Share (2018-2020)
Reason to Buy
- Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Pharma & Healthcare Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets